Introduction
============

Staphylococci are major commensal colonizers of healthy human skin and leading causes of hospital-acquired infections, responsible predominantly for wound and device-associated infections. Understanding skin survival mechanisms of staphylococci is vital, as individuals colonized by *Staphylococcus aureus* are at greater risk of infections during hospitalization ([@B35]; [@B14]).

Unlike those coagulase-negative staphylococci that are skin-dwelling, the primary human niche of coagulase-positive *S. aureus* is the nares, with skin colonization being transient and seeded from this location ([@B47]; [@B34]; [@B8]). A comparison of responses and resistance mechanisms between *S. aureus* and these closely related, long-term skin colonizers, such as *S. epidermidis*, therefore provides a useful tool to investigate functionalities required for skin colonization and persistence ([@B11]). Such investigations have increasing relevance with the emergence of community-acquired MRSA lineages, such as USA300 which cause increased skin pathology ([@B45]; [@B41]).

Atopic dermatitis is a disease presenting as dry, flaky skin lesions, abscesses, and unusually high levels of *S. aureus* skin colonization ([@B23]; [@B5]; [@B37]). Many host factors of skin are altered in atopic dermatitis, including levels of antimicrobial peptides, antimicrobial fatty acids, and sphingosines, all of which have been associated with *S. aureus* exclusion ([@B60]; [@B2]; [@B8]). Levels of sapienic acid in particular were determined to be inversely proportional to levels of *S. aureus* ([@B64]), identifying sapienic acid as a strong candidate host factor that contributes to prevention of long-term skin colonization by *S. aureus*.

Recent studies revealed the effects that sapienic acid and other skin fatty acids have on *S. aureus* survival ([@B33]; [@B7]; [@B49]). Together these studies showed that unsaturated long-chain fatty acids, including sapienic and linoleic acids, cause membrane depolarization in *S. aureus* leading to large transcriptional changes, especially those pathways associated with cellular energetics ([@B33]; [@B49]). From the transcriptomic response, it is inferred that the membrane depolarisation leads to disruption of the electron transport chain ([@B33]; [@B49]).

Here we show that the mean sapienic acid MIC of *S. epidermidis* strains is greater than *S. aureus*. Consequently, RNA-Seq was used to compare sapienic acid transcriptional responses with the aim of highlighting skin survival determinants. These investigations form the basis to determine whether sapienic acid responses discriminate staphylococcal species based on their skin-dwelling propensity.

Materials and Methods {#s1}
=====================

Bacterial Strains and Culture
-----------------------------

Strains used in this study are listed in **Table [1](#T1){ref-type="table"}**. Overnight cultures were grown for 18 h at 37°C with shaking. Todd Hewitt broth (THB) or agar (THA) was used as the culture media for all experiments. Sapienic acid (Matreya) stock solution was prepared at 8 mg ml^-1^ in ethanol. Antibiotics were incorporated at concentrations of 12.5 μg ml^-1^ tetracycline, 100 μg ml^-1^ ampicillin, 10 μg ml^-1^ chloramphenicol, and 5 μg ml^-1^ erythromycin, when appropriate.

###### 

Strains used in this study.

  Species            Strain                  Description                                    Reference
  ------------------ ----------------------- ---------------------------------------------- ---------------
  *S. epidermidis*   Rp62a                   Intravascular catheter isolate                 [@B9], [@B10]
                     Tü3298                  Epidermin producer                             [@B1]
                     NCTC 1457               PIA producer                                   [@B44]
                     A19                     Recent skin (forearm) isolate                  [@B31]
                     B19                     Recent skin (forearm) isolate                  [@B31]
                     O16                     Recent skin (forearm) isolate                  [@B31]
                     BL115                   Recent nasal isolate                           [@B42]
  *S. aureus*        Newman                  Osteomyelitis isolate                          [@B18]
                     SH1000                  Lab strain (rsbU repaired 8325-4 derivative)   [@B25]
                     MSSA476                 Osteomyelitis isolate                          [@B24]
                     MRSA252                 Fatal bacteraemia isolate, MRSA                [@B24]
                     BL014                   Recent nasal isolate                           [@B42]
                     BL032                   Recent nasal isolate                           [@B42]
                     SF8300                  CA-MRSA                                        [@B16]
                     SF8300ax                SF8300 with ACME deletion                      [@B16]
                     Liv1245                 Newman arcA::tet from Liv692                   This study
                     Liv1247                 SF8300 arcA::tet from Liv692                   This study
                     Liv1249                 SF8300ax arcA::tet from Liv692                 This study
                     Liv692                  S. aureus SH1000 arcA::tet                     [@B33]
                     Newman tagO             tagO::ery from SA113 tagO                      This study
                     SA113 tagO              tagO::Ery                                      [@B3]
                     Newman *mcrA*           NWMN_0050:: Ery                                This study
                     Newman *mcrA* pSK5632   Newman *mcrA* containing pSK5632 + *mcrA*      This study
                     Liv1023                 *mtlD*::*tet* (SH1000)                         [@B32]
                     Liv1024                 *mtlABCD*::tet (SH1000)                        [@B32]
                     RN4220                  Restriction deficient strain                   [@B38]
                     SH1000 *mnhF*           *mnhF* in frame unmarked deletion              [@B59]
                                                                                            

Minimum Inhibitory Concentration Assay
--------------------------------------

Minimum inhibitory concentration (MIC) assays were performed using a broth microdilution method in 96 well plates, with final well volumes of 200 μl and a sapienic acid concentration range of 200--0.8 μg ml^-1^. An inoculum of ∼10^4^ CFU ml^-1^ was used.

Growth and Sapienic Acid Challenge
----------------------------------

Overnight broth cultures were adjusted to an OD~600~ of 0.5 then diluted 25-fold in fresh medium prior to incubation in a water bath with shaking (250 rpm) at 37°C. Sapienic acid/ethanol was added to cell cultures in mid-exponential phase (OD~600~ ∼0.5) with equivalent volumes of ethanol added to control cultures. For RNA-Seq experiments, cells were harvested by centrifugation 20 min after challenge and suspended in RNA*later* (Qiagen).

RNA Extraction and Library Preparation
--------------------------------------

For cell lysis, bacteria were pelleted at 6,000 RCF for 5 min at 4°C and suspended in 100 μl TE containing 6 mg ml^-1^ lysostaphin and 400 U ml^-1^ mutanolysin. Lysis was performed for 15 min at 37°C for *S. aureus* and 30 min for *S. epidermidis*. Subsequently, samples were treated with 25 μl of proteinase K (Qiagen) for 30 min at 37°C. RNA was extracted using the RNeasy kit (Qiagen). Samples were DNase-treated using turbo DNase (Ambion), and the DNase removed using the RNeasy MinElute clean up kit (Qiagen).

Depletion of rRNA was achieved with a Ribo-Zero magnetic kit for Gram-positive bacteria (Epicentre). The concentration of RNA was normalized before library construction using strand specific ScriptSeq kits (Epicentre); libraries were prepared by the Centre for Genomic Research (CGR), Liverpool. RNA-Seq samples were sequenced by paired-end sequencing using the HiSeq platform (Illumina).

RNA-Seq Differential Expression Analysis
----------------------------------------

Bowtie ([@B40]) and Edge R ([@B57]; [@B56]) were used to map reads and determine the differentially expressed (DE) genes, respectively. Genes with mapped transcripts that had a false discovery rate \<0.05, as determined by Benjamin and Hochberg analysis, were considered differentially expressed between control and test conditions.

Gene expression changes in biosynthetic pathways were associated using KEGG mapper-search and color ([@B29]; [@B30]). The *S. aureus* transcriptome meta-database (SATMD) ([@B48]) was used to compare sapienic acid DE gene sets with existing *S. aureus* DE gene sets.

cDNA Generation and qPCR
------------------------

The tetro cDNA synthesis kit (Bioline) was used for cDNA synthesis using random hexamer primers and 2 μg RNA per reaction. **Table [2](#T2){ref-type="table"}** lists the qPCR primers. Novel primers were designed using primer-BLAST ([@B66]). Primer efficiency for all primers was confirmed to be within 90--100% as described previously ([@B52]). All qPCR reactions were performed using SensiFAST SYBR Hi-ROX kit (Bioline) with the ABI StepOnePlus (Life Technologies); data analysis used the ABI StepOnePlus software. At least two technical replicates and three biological replicates were used to determine fold change in gene expression between samples.

###### 

Primers used in this study.

  Gene name                  Primer sequences                                                                                                                          Efficiency (%)   Reference
  -------------------------- ----------------------------------------------------------------------------------------------------------------------------------------- ---------------- ------------
  *rpoB*                     F-GCGAACATGCAACGTCAAGR-GACCTCTGTGCTTAGCTGTAATAGC                                                                                          97.0             This study
  *hu*                       F-TTTACGTGCAGCACGTTCACR-AAAAAGAAGCTGGTTCAGCAGTAG                                                                                          90.3             [@B17]
  *gyrB* Tü3298              F-AGAAAAGATGGGACGCCCTGR-CACCATGAAGACCGCCAGAT                                                                                              96.6             This study
  *gyrB* Newman              F-ATCGACTTCAGAGAGAGGTTGR-CCGTTATCCGTTACTTTAATCCA                                                                                          92.9             [@B33]
  *capB*                     F-GCGATATGCGTAAGCCAACACR-GGTACAGGGCCAGCTGTTAG                                                                                             91.5             This study
  *pyrP*                     F-CGATGTTTGGCGCAACAGTAR-GCTGGTATTTGCGCCTTCG                                                                                               92.5             This study
  *clpB*                     F-TGGTGCACCTCCAGGTTATGR-AGAATCCGTAAGACGACCTTCA                                                                                            99.0             This study
  *farR*                     F-ACGCCAGCTGTGTGGATTATR-AACGACTGCGACCTTGATGT                                                                                              93.3             This study
  *sasF*                     F-TCACTCTGCGATTGAAGGCAR-TTTCCGGTGCCGAATGATCT                                                                                              95.0             This study
  *narH*                     F-TGGCCTTTCCATTGCATCCTR-TTCAGTGTCGCCAGCAGTTA                                                                                              93.6             This study
  *mcrA* (gene knockout)     F1-ACATGAATTCGGAATTGGTTAAGTTCACTCR1-CCGGTACCAGAACTCATCTAATA CAGACF2-ATAACTGCGGCCGCTGTATCACTTAGGTGTATCAR2-CGACGGATCCTCCAGCTGTTACCAGTCCGA   --               This study
  *mcrA* (complementation)   F-TTACGGATCCTTAAGTAACTTCTTTCAAR-TTATAAAGCTTACATCATTTCTGTCCCAG                                                                             --               This study
                                                                                                                                                                                        

Construction of Gene Mutants
----------------------------

An allelic replacement mutant of NWMN_0050 and complementation of this mutant were constructed using the previously described method of [@B26] using the primers listed in **Table [2](#T2){ref-type="table"}**. Allelic replacement mutants of *tagO* and *arcA* in strain Newman were generated by phage transduction ([@B27]) from previously described mutants (**Table [1](#T1){ref-type="table"}**).

Data Accession Numbers
----------------------

The complete genome sequence of *S. epidermidis* Tü3298 is available at <http://www.ebi.ac.uk/ena/data/view/PRJEB11651> ([@B46]). The Illumina sequence read data generated from the RNA-Seq experiments are available from ArrayExpress database^[1](#fn01){ref-type="fn"}^ under accession number E-MTAB-4587.

Results and Discussion
======================

Comparative Sapienic Acid Resistance
------------------------------------

We hypothesized that differences in sapienic acid resistance might contribute to the higher frequency and persistence of *S. epidermidis* on healthy human skin relative to *S. aureus*. Consistent with our hypothesis, we identified that the mean sapienic acid MIC of *S. epidermidis* was approximately three times higher than that of *S. aureus* strains (*p* = 0.023) (**Figure [1](#F1){ref-type="fig"}**).

![**Sapienic acid minimum inhibitory concentration (MICs) of *S. aureus* and *Staphylococcus epidermidis* strains.** MICs were determined using the broth microdilution method. MICs are the lowest concentration found to inhibit growth. The dotted line shows the mean MIC of each species.](fmicb-08-00033-g001){#F1}

Previous studies revealed that *S. aureus* colonizes the skin of atopic dermatitis sufferers, and its colonization frequency inversely correlates with sapienic acid levels ([@B64]). Sapienic acid is not the only factor on atopic skin to be linked with *S. aureus* colonization, and levels of other skin lipids and antimicrobial peptides are also linked with colonization ([@B60]; [@B2]; [@B8]). Although sapienic acid is antimicrobial it remains to be demonstrated that within sebum its activity *in vivo* reduces *S. aureus* colonization. These *in vitro* data presented here support a hypothesis that sapienic acid resistance contributes to skin colonization and persistence. The differential survival data are consistent with the increased frequency of staphylococci, not only *S. aureus*, on skin of atopic dermatitis patients whose skin lipid levels are reduced ([@B37]; [@B62]).

While *S. epidermidis* strains exhibited a greater sapienic acid MIC compared with *S. aureus*, *S. epidermidis* growth was inhibited by lower concentrations than skin colonizing corynebacteria. For example, *Corynebacterium stratum* which colonizes sebaceous niches has up to 10 times greater sapienic acid MIC ([@B20]) than the *S. epidermidis* strains studied here.

Growth of Sapienic Acid-Challenged *S. aureus* and *S. epidermidis*
-------------------------------------------------------------------

Similar to findings of our previous study of the *S. aureus* response to linoleic acid ([@B33]), sapienic acid was reported by [@B49] to induce a major adaptive transcriptional response in *S. aureus* SH1000. We therefore hypothesized that comparison of the transcriptional responses of *S. aureus* with *S. epidermidis* might identify differential skin survival mechanisms of these species relating to antimicrobial lipids that might also account for their MIC differences. Since we were interested in the typical response of each species, strains *S. aureus* Newman and *S. epidermidis* Tü3298 were selected, being representative of each species based on their MICs.

We used a similar experimental design to our previous linoleic acid transcriptional response study ([@B33]), substituting microarrays with RNA-Seq for transcriptomics. Both staphylococci were grown to mid-log phase and challenged with the lowest concentration of sapienic acid that caused an equivalent growth rate reduction (**Figure [2](#F2){ref-type="fig"}**), specifically, 11.25 μM for *S. aureus* Newman and 15 μM for *S. epidermidis* Tü3298. The transcriptomes of each species were determined under challenge and control conditions using RNA-Seq, with resolution of the differentially expressed genes between these conditions.

![**Growth of *S. aureus* Newman** **(A)** and *S. epidermidis* Tü3298 **(B)** challenged with sapienic acid. Bacteria were grown to OD~600~ = 0.5 before addition of sapienic acid (dotted line). Sapienic acid was added to concentrations 7.5 μM (cross), 11.25 μM (triangle) and 15 μM (circle)-Tü3298 only- or no addition, 0 μM (diamond).](fmicb-08-00033-g002){#F2}

Sapienic Acid Challenge Transcriptomes
--------------------------------------

In response to sapienic acid challenge, *S. aureus* Newman showed 1224 significantly differentially expressed (DE) genes; 630 genes were upregulated and 594 were downregulated (**Supplementary Table [S1A](#SM1){ref-type="supplementary-material"}**). *S. epidermidis* Tü3298 showed 1505 significantly DE genes in response to sapienic acid challenge; 708 genes were upregulated and 797 were downregulated (**Supplementary Table [S1B](#SM1){ref-type="supplementary-material"}**). A greater proportion of DE genes across the genome was observed for *S. epidermidis* Tü3298 (64.5% of 2332 total genes) compared with *S. aureus* Newman (45.6% of 2686 total genes).

Based on their homologous gene content, the sapienic acid transcriptomes of *S. aureus* and *S. epidermidis* were compared, which revealed 525 shared DE genes with a common regulation pattern (**Figure [3](#F3){ref-type="fig"}**, **Supplementary Table [S1C](#SM1){ref-type="supplementary-material"}**). Thus, the common transcriptomic response represents less than one half or one third of the DE genes of *S. aureus* and *S. epidermidis*, respectively. For both species, a selection of DE genes were confirmed using qPCR (**Supplementary Figure [S1](#SM3){ref-type="supplementary-material"}**).

![**Differentially expressed genes of *S. aureus* and *S. epidermidis* post challenge with sapienic acid.** The number of homologous genes of *S. aureus* Newman and *S. epidermidis* Tü3298 (central circles) that were upregulated (red) or downregulated (blue) following sapienic acid challenge were compared. Numbers of upregulated and downregulated genes with no homologue in the other species are shown by the outer circles.](fmicb-08-00033-g003){#F3}

Similarities in regulation within the shared responses to sapienic acid are likely to reflect a common response to the membrane depolarization mode of action that disrupts function of the electron transport chain ([@B7]). Consistent with this mode of action, we identified upregulated transcription of genes required for sugar uptake, glycolysis, the TCA cycle, NADPH/NADP+ recycling and pyruvate metabolism (**Figure [4](#F4){ref-type="fig"}**). This shared response may enable the staphylococci to maintain ATP synthesis following disruption of energy generation at the membrane. Downregulated transcription was associated with genes for cell growth in both species (**Figure [5](#F5){ref-type="fig"}**), including peptidoglycan biosynthesis, cell membrane biosynthesis and DNA replication and repair. This response is consistent with adaptation of the bacteria to their changed environment, and with the growth lag observed following sapienic acid challenge of both *S. aureus* and *S. epidermidis* (**Figure [2](#F2){ref-type="fig"}**).

![**Changes in gene expression of carbon metabolism associated genes in *S. aureus* and *S. epidermidis* challenged with sapienic acid**.](fmicb-08-00033-g004){#F4}

![**Changes in gene expression of growth associated genes in *S. aureus* and *S. epidermidis* challenged with sapienic acid**.](fmicb-08-00033-g005){#F5}

Downregulation of cell membrane glycerophospholipid biosynthesis genes, when combined with the upregulation of fatty acid degradation genes (*aldA*, NWMN_1858/SETU_01602, NWMN_2090/SETU_01661, NWMN_2091/SETU_01662), supports the description of sapienic acid incorporation into membrane lipids and lipoproteins in staphylococci ([@B54]).

Host fatty acids are metabolized in *S. aureus* by a fatty acid kinase consisting of FakA plus FakB1 or FakB2 subunits in the phospholipid biosynthesis pathway ([@B53]). The *fakA* and *fakB1* genes were downregulated in both *S. aureus* Newman and *S. epidermidis* Tü3298. Gene *fakB2* was upregulated only in *S. epidermidis*; since FakB2 binds long chain unsaturated fatty acids this supports sapienic acid incorporation into the cell phospholipid in this species. Incorporation of AFAs into cellular lipoproteins and phospholipids was suggested as a detoxification mechanism ([@B15]), while incorporation of fatty acids into lipoproteins enhances the immune response against *S. aureus* ([@B50]).

Sapienic Acid Transcriptome and Niche Colonization
--------------------------------------------------

The levels of topical skin lipids vary across the body surface ([@B39]), and sebaceous richness inversely correlates with staphylococcal frequency ([@B12]; [@B11]). Cutaneous skin lipids, including sapienic acid, have potential to act as environmental cues for niche adaptation, particularly with the extensive sapienic acid-dependent transcription changes observed that indicate major transcriptome reprofiling in both staphylococci studied here.

Such an environmentally responsive pathway could correspond to the reduced virulence factor expression mediated by SaeRS in response to sapienic acid in *S. aureus*, which may promote its colonization over infection ([@B49]). *S. aureus* Newman used in this study has an *saeS* mutation, resulting in constitutive expression of the SaeRS two-component system regulon ([@B13]). This mutation likely explains the lack of differential expression of hemolysins in the *S. aureus* Newman data set. The *saeRS* operon homologs in *S. epidermidis* (SETU_00325 and SETU_00326, respectively) were not differentially expressed in response to sapienic acid. Moreover, genes of the *S. epidermidis* SaeRS regulon ([@B22]) did not show any particular expression pattern that would suggest this regulon was modulated. On this basis, we propose that SaeRS is not a key regulator of the sapienic acid survival response of *S. epidermidis*.

Sapienic acid responsive gene expression changes included determinants that protect staphylococci from innate immune defenses of the skin. Adhesin genes implicated in colonization of the nose and skin, such as *sdrC* in *S. aureus* Newman and *ebh* genes in *S. epidermidis* Tü3298, were upregulated (7.4 and 1.3--2.6 fold, respectively) after challenge (**Supplementary Table [S1](#SM1){ref-type="supplementary-material"}**). In response to sapienic acid *S. aureus* Newman markedly upregulated (2.8--52.5 fold) capsule biosynthesis genes, approximating the response that we previously reported of *S. aureus* MRSA252 to linoleic acid ([@B33]). Despite this pronounced upregulation of capsule biosynthesis genes, [@B49] identified that capsule deficient mutants do not have altered sapienic acid survival, at least for the laboratory strain SH1000 they studied.

Comparing each species' response to sapienic acid there is further distinction between two-component signal transduction systems. The sapienic acid response of *S. epidermidis* Tü3298 includes upregulation of the *vraD* and *vraE* which encode an ABC transporter, important for bacitracin resistance. Contrastingly *vraDE* is not differentially expressed in *S. aureus* Newman. The VraDE transporter is regulated by the GraRS two-component system, that responds to cationic antimicrobial peptides ([@B55]). Resistance to cationic antimicrobial peptides is an important factor in skin colonization and marks out a further distinction between the responses of each species to sapienic acid, with the potential for a coordinated antimicrobial response in *S. epidermidis*.

Sapienic Acid Transcriptomes and Resistance
-------------------------------------------

Comparison of the sapienic acid transcriptomes of *S. aureus* and *S. epidermidis* revealed candidate genes that might be associated with sapienic acid resistance based upon their upregulation or presence in a pathway. The contribution of these genes to resistance was explored with allelic replacement mutants.

Genes of the *mnhABCDEFG* operon were all considerably upregulated in *S. aureus* (4.7--6.8 fold change), though less upregulated in *S. epidermidis* (1.3--1.9 fold change) after sapienic acid challenge. Analysis of transcript abundance data (**Figure [6](#F6){ref-type="fig"}**) revealed that expression of the *mnh* operon was high in *S. epidermidis* during normal growth (control) conditions (232--1341.3 FPKM), while little expression was evident in *S. aureus* in these conditions (22.3--124.1 FPKM). A *mnhF* in-frame deletion mutant was investigated here for a role in sapienic resistance and had a twofold reduction in MIC (24 μg ml^-1^) compared with isogenic *S. aureus* SH1000 (48 μg ml^-1^). A recent study by [@B59] determined that *mnhF* confers resistance to bile salts through efflux of cholic acid. Several *mnh* genes encode Mrp family secondary antiporter proteins associated with cation/proton transport which can increase the transmembrane electrical potential in staphylococci ([@B63]).

![**Gene expression of the *mnh* operon under control conditions (red) or following sapienic acid challenge (blue).** Mapped reads for replicate RNA-Seq data were visualized in integrated genome browser (IGB).](fmicb-08-00033-g006){#F6}

In addition to the *mnh* operon, multiple putative cation antiporters and osmoprotectant transporters were upregulated in response to sapienic challenge in *S. aureus* (NWMN_2457, NWMN_2050, NWMN_2089 and NWMN_0690) and *S. epidermidis* (SETU_02263 and SETU_00248-00254). The transcriptional upregulation of these transporters may protect the cell from the effects of solute leakage and membrane depolarization caused by sapienic acid ([@B21]; [@B54]).

In response to sapienic acid challenge, *S. epidermidis* and *S. aureus* upregulate expression of different metabolic pathways that generate ammonia. *S. aureus* upregulated the urease operon (12.2--13.4 fold) with no consistent differential expression of this operon in *S. epidermidis* (**Figure [7](#F7){ref-type="fig"}**). In contrast, *S. epidermidis* upregulated *arcC* (1.7-fold) of the arginine deiminase pathway while the *arc* operon was not DE in *S. aureus. S. epidermidis* also upregulated the oxygen-responsive NreABC nitrogen regulation system (1.9--2.5 fold) and likewise upregulated the nitrate and nitrite reduction pathways (1.6--3.6 and 1--2.2 fold, respectively). Nitrate and nitrite dissimilation is coupled to the generation of a proton motive force in anoxic conditions and nitrite dissimilation generates cytoplasmic ammonia ([@B61]). The *arc*, nitrate and nitrite reductase operons are induced in staphylococci only in the absence of oxygen ([@B19]; [@B43]; [@B51]), further supporting that there is reduced uptake or altered perception of oxygen following sapienic acid challenge. *S. epidermidis* using nitrate as an alternative acceptor for its electron transport chain might offer considerable metabolic flexibility compared with *S. aureus*.

![**Gene expression changes in ammonia and ammonium producing processes arginine deiminase pathway** **(A)**, urease activity **(B)** and the nitrate reductase pathway **(C)** in *S. aureus* and *S. epidermidis*. Proteins within pathways are colored for *S. aureus* Newman (left) and *S. epidermidis* Tü3298 (right) for changes in gene expression following sapienic acid challenge.](fmicb-08-00033-g007){#F7}

We previously determined that expression of the arginine deiminase pathway operon (*arcABC*) contributes to *S. aureus* linoleic acid resistance ([@B33]). The arginine deiminase pathways encoded chromosomally or on the ACME element *arc* both result in ammonia production, so here we tested if either of these operons contribute to sapienic acid resistance. The sapienic acid MIC was determined for *S. aureus* SF8300 and its isogenic ACME element deletion mutant, SF8300ax; the MIC of the mutant was twofold lower than its parent strain (**Figure [8](#F8){ref-type="fig"}**). The sapienic acid MIC of the chromosomal *arcA* mutants of *S. aureus* SF8300 and Newman were also twofold lower than their parent strains. While there was no difference in the MIC of SF8300ax and SF8300ax *arcA* mutant, there was a consistent reduction in growth of the SF8300ax *arcA* mutant compared with SF8300ax (at 3 μg/ml sapienic acid in the MIC assay mean OD~600=~ 0.41 and 0.94, respectively) (**Figure [8](#F8){ref-type="fig"}**).

![**Sapienic acid MICs of *S. aureus* wild type and mutant strains.** MICs were determined using the broth microdilution method. MICs are the lowest concentration found to inhibit growth. Mutants of genes predicted to be important in sapienic acid resistance due to RNA Seq data were contructed or obtained.](fmicb-08-00033-g008){#F8}

Staphylococcal myosin cross reactive antigen (McrA) homologs were previously proposed as antimicrobial lipid resistance determinants ([@B11]) due to their similarity with fatty acid hydratases of streptococci ([@B4]; [@B65]; [@B58]; [@B28]). Following sapienic acid challenge there was increased expression of the *mcrA* gene homologs (NWMN_0050 and SETU_00673), 7.4 and 5.4-fold, respectively in *S. aureus* and *S. epidermidis*. Fatty acid hydratase enzymes convert unsaturated fatty acids into their saturated counterparts, which is a detoxification mechanism for oleic acid in *Streptococcus pyogenes* ([@B65]). The staphylococcal McrA has no obvious secretion motifs making it unlikely to act on extracellular sapienic acid, though it could act to facilitate its metabolism intracellularly. Here, allelic replacement of *mcrA* in *S. aureus* was achieved to investigate its contribution to resistance. Somewhat unexpectedly, the sapienic acid MIC of *S. aureus* Newman *mcrA* (*NWMN_0050*) was greater (48 μg ml^-1^) than its isogenic parent strain (6 μg ml^-1^) (**Figure [8](#F8){ref-type="fig"}**). This increased resistance phenotype was reversed in the Newman *mcrA* pSK5632+*mcrA* complementation strain, which had the same MIC as the wild type. Mutation of *mcrA* takes the survival of *S. aureus* Newman to a level of sapienic acid survival similar to a *S. epidermidis* strain. This indicates that an inability to saturate sapienic acid to palmitic acid through McrA acitivity, or a distinct cellular lipid conversion by McrA impacts *S. aureus* survival. By comparison, the *mcrA* gene (SETU_006730) of *S. epidermidis* Tü3298 contains a premature stop codon, indicating this gene activity may not be functional.

Wall teichoic acid (WTA) deficient mutants have reduced MIC for antimicrobial fatty acids ([@B36]) and here, *S. aureus* Newman *tagO* was shown to have a very reduced sapienic acid MIC (\< 0.8 μg ml^-1^), over eight times lower than its isogenic wild type strain (**Figure [8](#F8){ref-type="fig"}**). Despite its importance for survival, genes of the WTA biosynthesis pathway were downregulated in both species (*tagA*, *tagG*, *dltX*, and *gtaB* in *S. aureus*, *tagB* and *tagF*/*tarF* in *S. epidermidis*). In addition, both *S. epidermidis* and *S. aureus* downregulated *dlt*, *mprF*, and *isdA* genes which would be predicted to increase cell hydrophobicity, but these transcription changes may reflect peptidoglycan modification genes mirroring a reduction in cell wall biosynthesis during a period of reduced growth post sapienic acid challenge.

*S. epidermidis* Specific Resistance Determinants
-------------------------------------------------

Key sapienic acid resistance determinants that differentiate the increased *S. epidermidis* sapienic acid MIC from *S. aureus* might be identifiable from their signature of transcription upregulation and/or presence only in the *S. epidermidis* data set. Of those 38 genes upregulated \>2-fold in *S. epidermidis* with no homolog in *S. aureus*, 12 are annotated with transport functions (**Supplementary Table [S2](#SM1){ref-type="supplementary-material"}**). These genes may counteract the leakage of solutes caused by sapienic acid ([@B21]; [@B54]); transport of osmolytes is a key resistance mechanism used by staphylococci during acid stress, where there is also accompanying membrane depolarization ([@B6]). A further nine genes of the 38 were hypothetical genes, revealing a need to evaluate potential resistance determinants within this gene set.

Conclusion
==========

*S. epidermidis* strains have greater sapienic resistance than *S. aureus*. The transcriptional responses of *S. aureus* and *S. epidermidis* to sapienic acid reveal that in addition to a shared stimulon, there are multiple distinct pathways modulated in each species. Our data identifies potential roles for the use of alternative respiration pathways, ammonia production and cation/osmolyte transport in differential survival from sapienic acid.
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